MR-1006

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMR-1006
Drug Alias Nameanti-GPVI antibody (Mochida)Anti-GPVI mAb (Mochida)MR-1006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlatelet membrane glycoprotein VI inhibitors
TargetsPlatelet membrane glycoprotein VI
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A